-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Tag Archives: Pharmacy
The Compounding Shop FDA News Release
Translation The Compounding Shop: FDA News Release – Lack of Sterility Assurance of Drug Products AUDIENCE: Pharmacy, Healthcare Professionals, Patients ISSUE: The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that the FDA’s … Continue reading
Posted in FDA 2013, FDA Safety Communication, Healthcare Professionals, Patients, Pharmacy
Tagged drug risks, Drug Safety Communication, FDA News Release, FDA notice, Healthcare Professionals, Patients, Pharmacy, Safety Communication, The Compounding Shop, The Compounding Shop: FDA News Release
Comments Off
Valproate Anti-Seizure Products Drug Safety Communication
TranslationValproate Anti-Seizure Products: Drug Safety Communication – Contraindicated for Pregnant Women for Prevention of Migraine Headaches Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics AUDIENCE: Health Professional, Neurology, … Continue reading
Posted in FDA 2013, FDA Safety Communication, Healthcare Professionals, Neurology, Patients, Pharmacy
Tagged anti-seizure medication, Anti-Seizure Products, divalproex sodium, Drug Safety Communication, Health Professional, Neurology, Patient, Pharmacy, pregnant women, Valproate, Valproate Anti-Seizure Products Drug Safety Communication, valproate sodium, valproic acid
Comments Off
Kadcyla ado-trastuzumab emtansine Drug Safety Communication
TranslationKadcyla (ado-trastuzumab emtansine): Drug Safety Communication – Potential Medication Errors Resulting from Name Confusion AUDIENCE: Risk Manager, Pharmacy, Oncology ISSUE: The FDA notified health care professionals that the use of the incorrect nonproprietary name for the breast cancer drug Kadcyla … Continue reading
Newport Medical Instruments Inc HT70 HT70 Plus Ventilators Class I Recall
TranslationNewport Medical Instruments, Inc., HT70 and HT70 Plus Ventilators: Class I Recall – Unit Goes Into Internal Backup Battery Sooner Than Expected AUDIENCE: Risk Manager, Nursing ISSUE: The recall is in response to customer reports of Newport Medical Instrument’s HT70 … Continue reading
Posted in FDA 2013, FDA Recall, Nursing, Risk Manager
Tagged Class 1 Recall, Class I Recall, FDA recall, HT70, Newport Medical Instruments Inc, Newport Medical Instruments Inc HT70 HT70 Plus Ventilators Class I Recall, Nursing, Pharmacy, Plus Ventilators, Recall, Risk Manager, Risk Managers
Comments Off
Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD) BLOOD-PACK Unit Fenwal Recall
TranslationAnticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit By Fenwal: Recall – Labeling Issue Identified Read the MedWatch Safety Alert, including links to the Recall at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350275.htm AUDIENCE: Risk Manager, Health Professional, Pharmacy ISSUE: Fenwal has initiated a … Continue reading
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Pharmacy, Risk Manager
Tagged (CPD), Anticoagulant Citrate Phosphate Dextrose Solution, Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD) BLOOD-PACK Unit Fenwal Recall, BLOOD-PACK Unit, Dietary Supplements, drug risks, FDA recall, Fenwal, Health Professional, Pharmacy, Recall, Risk Manager, Risk Managers, USP)
Comments Off
Samsca Tolvaptan Drug Safety Communication
TranslationSamsca (Tolvaptan): Drug Safety Communication – FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death AUDIENCE: Pharmacy, Health Professional, Patient ISSUE: FDA has determined that the drug Samsca (tolvaptan) should not be used … Continue reading
Posted in FDA 2013, FDA Safety Communication, Healthcare Professionals, Patients, Pharmacy
Tagged drug risks, Drug Safety Communication, FDA notice, Health Professional, Patient, Pharmacy, Risk Managers, Safety Communication, Samsca, Samsca Tolvaptan Drug Safety Communication, tolvaptan
Comments Off
Sodium Chloride Injection 0.9 percent USP Hospira Recall
TranslationSodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall – Particulate Matter AUDIENCE: Pharmacy, Patient, Health Professional ISSUE: Hospira notified the public that last August it initiated a voluntary nationwide user-level recall of one lot of … Continue reading
Posted in FDA 2013, FDA Recall, Healthcare Professionals, Patients, Pharmacy
Tagged 09 percent USP, 100 mL Flexible Containers, drug risks, FDA recall, Health Professional, Hospira, Hospira Recall, Patient, Pharmacy, Recall, Sodium Chloride Injection, Sodium Chloride Injection 09 percent USP 100 mL Flexible Containers
Comments Off
LifeScan OneTouch Verio IQ Blood Glucose Meter Class I Recall
TranslationLifeScan, Inc. OneTouch Verio IQ Blood Glucose Meter – Class I Recall: Failure to Provide a Warning at Extremely High Blood Glucose Levels AUDIENCE: Consumer, Health Professional, Pharmacy ISSUE: At extremely high blood glucose levels of 1024 mg/dL and … Continue reading
Posted in Consumer Products, FDA 2013, FDA Recall, Healthcare Professionals, Pharmacy
Tagged Blood Glucose Meter, blood meter, Class 1 Recall, Class I Recall, Consumer, Consumer Products, diabetes, diabetic, drug risks, FDA recall, Health Professional, LifeScan, LifeScan OneTouch Verio IQ Blood Glucose Meter Class I Recall, OneTouch Verio IQ, Pharmacy, Recall, sugar levels
Comments Off
Sterile Compounded Products Nora Apothecary Alternative Therapies Recall
TranslationAll Sterile Compounded Products by Nora Apothecary And Alternative Therapies: Recall – Lack of Sterility Assurance AUDIENCE: Pharmacy, Patient, Health Professional ISSUE: Nora Apothecary & Alternative Therapies announced a voluntary multi-state recall of all sterile drug products compounded by the … Continue reading
Balanced Solutions All Sterile Compounded Products Recall
TranslationBalanced Solutions All Sterile Compounded Products: Recall – Lack of Sterility Assurance AUDIENCE: Pharmacy, Patient, Health Professional ISSUE: Balanced Solutions Compounding Pharmacy, LLC announced a voluntary recall of all lots of sterile products compounded by the pharmacy that are not … Continue reading